The Challenge

A decentralized CRO was looking to recruit Asthma patients aged 12 or over from across the US to participate in a phase IIIb study. The study was looking for individuals who have been diagnosed with asthma by a healthcare professional and are using a specific medication to control their asthma.

The CRO wanted to only pay for patients who ended up randomizing in the trial.

Get Started

The Solution

The CRO provided GoodLab with the landing pages and IRB approved content - within 24 hours GoodLab had listed the trial within their discovery platform. This resulted in 450 qualified visitors being driven to the landing page per day.

GoodLab agreed to only bill the CRO for patients who ended up randomizing in the trial.

Get Started

The Outcome

GoodLab is one of multiple external vendors delivering patients to the trial - despite this they are delivering over 60% of the traffic to the trial.

The trial is ongoing (as of August-2023) and GoodLab is currently delivering 3 randomizations per day.

Get Started